Novartis Czech Republic made a net profit of CZK 71.0 mil in 2017, down 6.08% compared to the previous year. Historically, between 2000 and 2017, the company's net profit reached a high of CZK 82.7 mil in 2015 and a low of CZK 2.15 mil in 2000.
The result implies a return on equity of 11.5% and a return on invested capital of 5.67% in 2017. That is compared to an average of 16.3% and 6.74% over the last five years.
The company has been operating with average EBITDA margin of 2.29% in the last 5 years and an average net margin of 1.38%.
Since 2012, the firm's net profit increased by 42.1% or an average of 7.27% a year.
You can see all the company’s data at Novartis Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
